Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ) | WebDisclosure

Basculer en Français

10066	Companies
205763	Keywords
136024	Articles
109099	Press releases

Headlines Articles Press releases Eckert & Ziegler Strahlen- Und Medizintechnik AG

Home
Companies
Eckert & Ziegler Strahlen- Und Medizintechnik AG

PRESS RELEASE

published on 05/14/2024 at 07:50, 1 year 10 months ago

Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed.
Eckert & Ziegler SE reports strong Q1 results with 17% sales increase and 41% rise in adjusted EBIT. Forecast for 2024 confirmed. Read more: https://www.ezag.com/fileadmin/user_upload/ezag/investors-financial-reports/englisch/euz124e.pdf

Adjusted EBIT Sales Increase 2024 Forecast Q1 Results Eckert & Ziegler SE
BRIEF

published on 04/22/2024 at 14:54, 1 year 11 months ago

Eckert & Ziegler: Boost in Q1 Sales and Earnings, 2024 Forecasts Unchanged

Sales Increase 2024 Forecast EBIT Growth Eckert & Ziegler SE Q1 Financial Results
BRIEF

published on 04/22/2024 at 14:54, 1 year 11 months ago

Eckert & Ziegler : augmentation des ventes et des bénéfices au premier trimestre, prévisions 2024 inchangées

Prévisions 2024 Croissance De L'EBIT Eckert & Ziegler SE Résultats Financiers Du Premier Trimestre Augmentation Des Ventes
PRESS RELEASE

published on 04/22/2024 at 14:49, 1 year 11 months ago

EQS-Adhoc: Eckert & Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed.
Eckert & Ziegler SE reports strong Q1 results with sales of EUR 67.6 million and net income of EUR 8.5 million. 2024 annual forecast confirmed

Sales Earnings 2024 Forecast Q1 Results Eckert & Ziegler SE
BRIEF

published on 03/22/2024 at 07:50, 2 years ago

Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023

2023 Financial Year Eckert & Ziegler Annual Results Financial Growth Radiopharmaceuticals
BRIEF

published on 03/22/2024 at 07:50, 2 years ago

Eckert & Ziegler poursuit sa croissance après un exercice 2023 réussi

Croissance Financière Résultats Annuels Eckert & Ziegler Exercice 2023 Produits Radiopharmaceutiques
PRESS RELEASE

published on 03/22/2024 at 07:45, 2 years ago

Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023
Eckert & Ziegler SE reports sales growth in 2023 financial year, with sales reaching €246.1 million. Expecting sales of nearly €265 million in 2024

Sales Growth EBIT Financial Year 2023 Eckert & Ziegler SE Radiopharmaceuticals
BRIEF

published on 03/21/2024 at 10:05, 2 years ago

Eckert & Ziegler Achieves Key Milestone with MDR Certification for Prostate Seeds

Eckert & Ziegler Patient Safety MDR Certification Prostate Seeds Brachytherapy
BRIEF

published on 03/21/2024 at 10:05, 2 years ago

Eckert & Ziegler franchit une étape clé avec la certification MDR pour les graines de prostate

Eckert & Ziegler Sécurité Du Patient Certification MDR Graines De Prostate Curiethérapie
PRESS RELEASE

published on 03/21/2024 at 10:00, 2 years ago

Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply
Eckert & Ziegler BEBIG GmbH, a subsidiary of Eckert & Ziegler SE, obtains MDR certification for proprietary prostate seeds from DEKRA Certification B.V., ensuring patient safety and long-term supply within the EU

DEKRA Certification Eckert & Ziegler MDR Certification Prostate Seeds Brachytherapy

Accesswire

Published on 03/23/2026 at 14:05, 55 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 1 hour ago

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 1 hour 55 minutes ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 2 hours 28 minutes ago

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 2 hours 30 minutes ago

Digi Power X to Announce 2025 Year End Financial Results on March 31st

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 14:41, 18 minutes ago

CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 30 minutes ago

Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 30 minutes ago

Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/23/2026 at 14:24, 36 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 03/23/2026 at 14:22, 38 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc

Les Echos

Published on 03/23/2026 at 08:10, 6 hours 50 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 20 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 20 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 20 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 20 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE